financetom
Business
financetom
/
Business
/
Market Chatter: Apple Supplier Biel Weighs Reviving Hong Kong IPO
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Market Chatter: Apple Supplier Biel Weighs Reviving Hong Kong IPO
Jul 17, 2025 4:38 AM

07:26 AM EDT, 07/17/2025 (MT Newswires) -- Apple ( AAPL ) supplier Biel Crystal Manufactory is considering reviving plans for a Hong Kong IPO following renewed listing activity in the financial center, Bloomberg News reported Thursday, citing people familiar with the matter.

The company has held preliminary talks with advisers and could seek to file documents with Hong Kong's stock exchange as soon as this year, according to the report.

Deliberations remain at an early stage and the company may still opt not to move forward with the offering, Bloomberg reported.

Biel Crystal Manufactory did not immediately respond to MT Newswires' request for comment.

(Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Chemtrade Logistics Income Fund Q3 revenue beats expectations
Chemtrade Logistics Income Fund Q3 revenue beats expectations
Nov 11, 2025
Overview * Chemtrade Q3 revenue grows 12.4% yr/yr, beating analyst expectations * Adjusted EBITDA for Q3 reaches record high, beating analyst estimates * Net earnings for Q3 decrease due tolosses related to the change in fair value of debentures and higher depreciation and amortization expense Outlook * Chemtrade expects 2025 Adjusted EBITDA guidance to be above C$503 mln * Company...
FDA names oncology chief Pazdur as top drug regulator following Tidmarsh exit
FDA names oncology chief Pazdur as top drug regulator following Tidmarsh exit
Nov 11, 2025
Nov 11 (Reuters) - The U.S. Food and Drug Administration said on Tuesday it has appointed Richard Pazdur, the agency's veteran oncology chief, as its new director of the Center for Drug Evaluation and Research. Pazdur, who leads the FDA's Oncology Center of Excellence, replaces George Tidmarsh, who resigned earlier this month amid serious concerns about his personal conduct, a...
Sanara MedTech to Discontinue Tissue Health Plus Operations After Review
Sanara MedTech to Discontinue Tissue Health Plus Operations After Review
Nov 11, 2025
05:19 PM EST, 11/11/2025 (MT Newswires) -- Sanara MedTech ( SMTI ) said Tuesday it is discontinuing operations of its Tissue Health Plus division after completing an evaluation of strategic alternatives. The company said the move is intended to improve operating efficiency and reallocate resources to its core surgical business. The winding down of Tissue Health Plus is expected to...
Centerspace Confirms Board Review of Strategic Alternatives
Centerspace Confirms Board Review of Strategic Alternatives
Nov 11, 2025
05:20 PM EST, 11/11/2025 (MT Newswires) -- Centerspace ( CSR ) said late Tuesday that its board has initiated a strategic review that may include a sale, merger, other business combinations, or continuing its existing strategy. The company said it has not set a timeline for the review and has yet to make any decisions on potential transactions. ...
Copyright 2023-2026 - www.financetom.com All Rights Reserved